InvestorsHub Logo
Followers 1
Posts 40
Boards Moderated 0
Alias Born 07/09/2003

Re: BiotechValues post# 1441

Tuesday, 10/20/2009 8:01:37 PM

Tuesday, October 20, 2009 8:01:37 PM

Post# of 2230
And the reasons are:

1. Poor profit margins
2. ROE<year ago qtr.
3. Net income down 40% over yr. ago qtr.
4. EPS down 33% from yr. ago qtr.
5. Revenues dropped 10% from yr. ago qtr.

On the plus side:

1. Growth has outpaced average competitors in industry
2. Extremely liquid
3. Improved cash flow
4. Net worth up 28% over yr. ago qtr.
5. Unlikely to face financial difficulties in NEAR future
6. Trading at discount to industry
7. Sales growth exceeds peers
8. Trend is friend and that's up since late '08
9. Fundamentals are good; i.e., more coal to clean, more control over obtaining it, future power plant plans, etc.

Street.com says "sell" and Jaywalk consensus says "hold"; so, contrarian foundation says "buy."